<label id="mboud"><meter id="mboud"></meter></label>

        <rt id="mboud"><small id="mboud"><strike id="mboud"></strike></small></rt>
        咨詢熱線

        15000266580

        當(dāng)前位置:首頁(yè) >產(chǎn)品中心>細(xì)胞庫(kù)>人腫瘤細(xì)胞、癌細(xì)胞>MEG-01人成巨核細(xì)胞白血病細(xì)胞

        人成巨核細(xì)胞白血病細(xì)胞

        簡(jiǎn)要描述:CRL-2021 MEG-01 人成巨核細(xì)胞白血病細(xì)胞,
        原代細(xì)胞|細(xì)胞系|細(xì)胞株|菌種;細(xì)胞庫(kù)管理規(guī)范,
        提供的細(xì)胞株背景清楚,提供參考文獻(xiàn)和培養(yǎng)條件!

        • 產(chǎn)品型號(hào):MEG-01
        • 廠商性質(zhì):生產(chǎn)廠家
        • 更新時(shí)間:2025-06-28
        • 訪  問(wèn)  量:2256

        產(chǎn)品分類

        Product Category

        詳細(xì)介紹

        CRL-2021 MEG-01 人成巨核細(xì)胞白血病細(xì)胞

        ATCC® Number: CRL-2021™

        Designations: MEG-01

        Depositors: M Tekeuchi, MJ Fitzgerald

        Biosafety Level: 1

        Shipped: frozen

        Medium & Serum: See Propagation

        Growth Properties: mixed, adherent and suspension

        Organism: Homo sapiens (human)

        Morphology: lymphoblast

        CRL-2021 MEG-01 人成巨核細(xì)胞白血病細(xì)胞

        Source: Disease: chronic myelogenous leukemia (CML)

        Cell Type: megakaryoblast;

        Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.


        CRL-2021 MEG-01

        Applications: transfection host (Nucleofection technology from Lonza)

        Antigen Expression: CD41 +; CD61 +; CDw14 +

        DNA Profile (STR): Amelogenin: X,Y

        CSF1PO: 10

        D13S317: 8

        D16S539: 9

        D5S818: 13

        D7S820: 11

        THO1: 7

        TPOX: 8,11

        vWA: 16

        Cytogenetic Analysis: hyperdiploid; modal number = 56 to 58; the Philadelphia chromosome (Ph1) is present

        Age: 55 years

        Gender: male

        Comments: The MEG-01 cell line was derived in 1983 at the Nagoya University School of Medicine, Nagoya, Japan from bone marrow cells taken from a patient in megakaryoblastic crisis of CML.

        The cells are positive for cytoplasmic Factor VIII and surface GPIIb/IIIa, periodic acid - Schiff (PAS) reaction, alpha naphthyl acetate esterase and acid phosphatase.

        They are negative for myeloperoxidase, alpha naphthyl butyrate esterase, naphthol AS-D chloroacetate esterase and alkaline phosphatase.

        The stain positively with monoclonal antibodies BA-1 (anti B cell, granulocyte), HPL-3 (anti gpIIb/IIIa) and 20.3 (anti monocyte, plaet).

        They are negative for other lymphoid and myeloid seris antigens.

        Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.

        Temperature: 37.0°C

        Subculturing: Protocol: Subcultures are prepared by scraping the adherent cells into the medium. From the resulting suspension dilute cells to a concentration 1-2 X 10exp5 cells/ml into fresh medium in a new flasks. Keep culture below approximate density of 10exp6 cells/ml.

        Subc*tion Ratio: A subc*tion ratio of 1:2 to 1:3 is recommended

        Medium Renewal: 2 to 3 times per week

        Subcultures are prepared by scraping the adherent cells into the medium, and diluting the resulting suspension into fresh medium in new flasks.

        Doubling Time: 36 to 48 hrs

        Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001

        recommended serum:ATCC 30-2020

        References: 23348: Ogura M, et al. Establishment of a novel human megakaryoblastic leukemia cell line, MEG- 01, with positive Philadelphia chromosome. Blood 66: 1384-1392, 1985. PubMed: 2998511

        CRL-2021 MEG-01





















        產(chǎn)品咨詢

        留言框

        • 產(chǎn)品:

        • 您的單位:

        • 您的姓名:

        • 聯(lián)系電話:

        • 常用郵箱:

        • 省份:

        • 詳細(xì)地址:

        • 補(bǔ)充說(shuō)明:

        • 驗(yàn)證碼:

          請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
        聯(lián)系方式

        郵箱:xiangfbio@163.com

        地址:上海市虹口區(qū)四平路710號(hào)7層

        咨詢熱線

        400-821-8510

        (周一至周日9:00- 19:00)

        在線咨詢
        • 掃一掃 微信咨詢

        Copyright©2025 上海復(fù)祥生物科技有限公司 All Right Reserved    備案號(hào):滬ICP備10013034號(hào)-2     sitemap.xml
        技術(shù)支持:化工儀器網(wǎng)    管理登陸
        主站蜘蛛池模板: 亚洲国产成人久久一区WWW| 亚洲毛片免费观看| 日本二区免费一片黄2019| 30岁的女人韩剧免费观看| 亚洲国产成人精品无码区在线观看| 亚洲第一页在线观看| 久久久久久精品免费看SSS| 成在线人永久免费视频播放| 亚洲欧美aⅴ在线资源| 成全视频在线观看免费高清动漫视频下载 | 久久久久亚洲精品影视| 亚洲午夜无码久久久久软件 | 久久国产乱子伦精品免费不卡 | 亚洲国产精品午夜电影| 无码av免费毛片一区二区| 亚洲一区二区三区久久久久| 国产日韩精品无码区免费专区国产 | 亚洲日产2021三区在线| 无码人妻久久一区二区三区免费丨| 亚洲宅男天堂在线观看无病毒| 亚洲一区二区观看播放| 日产乱码一卡二卡三免费| 美女扒开屁股让男人桶爽免费| 亚洲成人免费网站| 中文字幕在线日亚洲9| 免费永久国产在线视频| 亚洲熟妇无码一区二区三区| 色吊丝永久在线观看最新免费| 日韩在线视频线视频免费网站| 亚洲精品高清国产一线久久| 亚洲视频在线免费看| 久久精品亚洲日本波多野结衣| 成年性午夜免费视频网站不卡| 麻豆安全免费网址入口| 亚洲AV综合色区无码一区 | 亚洲情a成黄在线观看动漫尤物| 91精品免费久久久久久久久| 国产精品久久久久久亚洲影视| 国产成人综合亚洲亚洲国产第一页| 偷自拍亚洲视频在线观看| 亚洲欧洲美洲无码精品VA |